medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 18, 2024
Abstract
Individuals
with
schizophrenia
frequently
experience
co-occurring
substance
use,
including
tobacco
smoking
and
heavy
cannabis
use
disorders.
There
is
interest
in
understanding
the
extent
to
which
these
relationships
are
causal,
what
shared
genetic
factors
play
a
role.
We
explored
between
(Scz),
disorder
(CanUD),
ever-regular
(Smk)
using
largest
available
genome-wide
studies
of
phenotypes
individuals
African
European
ancestries.
All
three
were
positively
genetically
correlated
(r
g
s
=
0.17
–
0.62).Causal
inference
analyses
suggested
presence
horizontal
pleiotropy,
but
evidence
for
bidirectional
causal
was
also
found
all
even
after
correcting
pleiotropy.
identified
439
pleiotropic
loci
ancestry
data,
150
novel
(i.e.,
not
significant
original
studies).
Of
loci,
202
had
lead
variants
showed
convergent
effects
same
direction
effect)
on
Scz,
CanUD,
Smk.
Genetic
across
strong
correlations
risk-taking,
executive
function,
several
mental
health
conditions.
Our
results
suggest
that
both
pleiotropy
mechanisms
may
role
relationship
Smk,
longitudinal,
prospective
needed
confirm
relationship.
Translational Psychiatry,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 25, 2025
Advancements
in
single-cell
multimodal
techniques
have
greatly
enhanced
our
understanding
of
disease-relevant
loci
identified
through
genome-wide
association
studies
(GWASs).
To
investigate
the
biological
connections
between
eye
and
brain,
we
integrated
bulk
multiomic
profiles
with
GWAS
summary
statistics
for
eight
neuropsychiatric
five
ocular
diseases.
Our
analysis
uncovered
latent
factors
explaining
61.7%
genetic
variance
across
these
13
diseases,
revealing
diverse
correlational
patterns
among
them.
We
45
pleiotropic
91
candidate
genes
that
contribute
to
disease
risk.
By
integrating
profiles,
implicated
excitatory
neurons
microglia
as
key
contributors
eye-brain
connections.
Polygenic
enrichment
further
15
regulons
16
were
linked
comorbid
conditions.
Functionally,
neuron-specific
involved
axon
guidance
synaptic
activity,
while
microglia-specific
associated
immune
response
cell
activation.
In
sum,
findings
underscore
link
psychiatric
disorders
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 31, 2025
ABSTRACT
Genetic
research
on
nicotine
dependence
has
utilized
multiple
assessments
that
are
in
weak
agreement.
We
conducted
a
genome-wide
association
study
of
defined
using
the
Diagnostic
and
Statistical
Manual
Mental
Disorders
(DSM-NicDep)
61,861
individuals
(47,884
European
ancestry,
10,231
African
3,746
East
Asian
ancestry)
compared
results
to
other
nicotine-related
phenotypes.
replicated
well-known
at
CHRNA5
locus
(lead
SNP:
rs147144681,
p
=1.27E-11
ancestry;
lead
SNP
=
rs2036527,
6.49e-13
cross-ancestry
analysis).
DSM-NicDep
showed
strong
positive
genetic
correlations
with
cannabis
use
disorder,
opioid
problematic
alcohol
use,
lung
cancer,
material
deprivation,
several
psychiatric
disorders,
negative
respiratory
function
educational
attainment.
A
polygenic
score
predicted
DSM-5
tobacco
disorder
6
11
individual
diagnostic
criteria,
but
none
Fagerström
Test
for
Nicotine
Dependence
(FTND)
items,
independent
NESARC-III
sample.
In
genomic
structural
equation
models,
loaded
more
strongly
previously
identified
factor
general
addiction
liability
than
did
“problematic
use”
(a
combination
cigarettes
per
day
by
FTND).
Finally,
was
genetically
correlated
GWAS
as
electronic
health
records,
suggesting
combining
wide
availability
EHR
data
nuanced
criterion-level
analyses
DSM
may
produce
new
insights
into
genetics
this
disorder.
Psychiatry Research,
Journal Year:
2024,
Volume and Issue:
333, P. 115758 - 115758
Published: Feb. 3, 2024
We
characterized
the
genetic
architecture
of
attention-deficit
hyperactivity
disorder-substance
use
disorder
(ADHD-SUD)
relationship
by
investigating
correlation,
causality,
pleiotropy,
and
common
polygenic
risk.
Summary
statistics
from
genome-wide
association
studies
(GWAS)
were
used
to
investigate
ADHD
(Neff=51,568),
cannabis
(CanUD,
Neff=161,053),
opioid
(OUD,
Neff=57,120),
problematic
alcohol
(PAU,
Neff=502,272),
tobacco
(PTU,
Neff=97,836).
ADHD,
CanUD,
OUD
GWAS
meta-analyses
included
cohorts
with
case
definitions
based
on
different
diagnostic
criteria.
PAU
combined
information
related
disorder,
dependence,
items
consequences
assessed
disorders
identification
test.
PTU
was
generated
a
multi-trait
analysis
including
regarding
Fagerström
Test
for
Nicotine
Dependence
cigarettes
per
day.
Linkage
disequilibrium
score
regression
analyses
indicated
positive
correlation
OUD,
PAU,
PTU.
Genomic
structural
equation
modeling
showed
that
these
correlations
two
latent
factors:
one
other
PAU.
had
larger
causal
effect
than
reverse
in
two-sample
Mendelian
randomization
analyses.
Conversely,
similar
sizes
found
between
CanUD.
CADM2
rs62250713
pleiotropic
SNP
all
SUDs.
seven,
one,
twenty-eight
variants
PTU,
respectively.
Finally,
PRS
associated
increased
odds
ADHD.
Our
findings
demonstrated
contribution
multiple
mechanisms
comorbidity
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 10, 2024
Abstract
The
etiology
of
substance
use
disorders
(SUDs)
and
psychiatric
reflects
a
combination
both
transdiagnostic
(i.e.,
common)
disorder-level
independent)
genetic
risk
factors.
We
applied
genomic
structural
equation
modeling
to
examine
these
factors
across
SUDs,
psychotic,
mood,
anxiety
using
genome-wide
association
studies
(GWAS)
European-(EUR)
African-ancestry
(AFR)
individuals.
In
EUR
individuals,
represented
SUDs
(143
lead
single
nucleotide
polymorphisms
[SNPs]),
psychotic
(162
SNPs),
mood/anxiety
(112
SNPs).
identified
two
novel
SNPs
for
that
have
probable
regulatory
roles
on
FOXP1
,
NECTIN3
BTLA
genes.
AFR
(1
SNP)
(no
significant
SUD
factor
SNP,
although
previously
in
EUR-
cross-ancestry
GWAS,
is
finding
Shared
variance
accounted
overlap
between
their
comorbidities,
with
second-order
GWAS
identifying
up
12
not
significantly
associated
either
first-order
Finally,
common
independent
effects
showed
different
associations
psychiatric,
sociodemographic,
medical
phenotypes.
For
example,
the
components
schizophrenia
bipolar
disorder
had
distinct
affective
risk-taking
behaviors,
phenome-wide
conditions
tobacco
broader
factor.
Thus,
combining
approaches
can
improve
our
understanding
co-occurring
increase
specificity
discovery,
which
critical
demonstrate
considerable
symptom
etiological
overlap.
Molecular Psychiatry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 5, 2024
Abstract
Cannabis
use
disorder
(CanUD)
has
increased
with
the
legalization
of
cannabis.
Around
20%
individuals
using
cannabis
develop
CanUD,
and
number
users
grown
increasing
ease
access.
CanUD
other
substance
disorders
(SUDs)
are
associated
phenotypically
genetically.
We
leveraged
new
genomics
data
to
undertake
genetically-informed
analyses
unprecedented
power,
investigate
genetic
architecture
causal
relationships
between
lifetime
risk
for
developing
SUDs
traits.
Analyses
included
calculating
local
global
correlations,
genomic
structural
equation
modeling
(genomicSEM),
Mendelian
Randomization
(MR).
Results
from
correlation
genomicSEM
demonstrated
that
differ
in
their
found
significant
effects
influencing
all
analyzed
traits:
opioid
(OUD)
(Inverse
variant
weighted,
IVW
β
=
0.925
±
0.082),
problematic
alcohol
(PAU)
(IVW
0.443
0.030),
drinks
per
week
(DPW)
0.182
0.025),
Fagerström
Test
Nicotine
Dependence
(FTND)
0.183
0.052),
cigarettes
day
0.150
0.045),
current
versus
former
smokers
0.178
smoking
initiation
0.405
0.042).
also
evidence
bidirectionality
showing
OUD,
PAU,
initiation,
cessation,
DPW
increase
CanUD.
For
use,
bidirectional
were
inferred
DPW;
was
a
higher
OUD
0.785
0.266).
GenomicSEM
confirmed
load
onto
different
factors.
conclude
can
SUDs.
This
substantial
public
health
implications;
move
towards
may
be
expected
kinds
use.
These
harmful
outcomes
addition
medical
harms
directly
Frontiers in Psychiatry,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 7, 2025
Cannabis
use
and
misuse
are
surging
among
the
Chinese
community
in
East
Southeast
Asia.
A
quick
screening
instrument
that
can
effectively
identify
users
with
dependence
for
early
intervention
is
utmost
need.
This
study
examined
psychometric
properties
of
version
Severity
Dependence
Scale
cannabis
(C-SDS-C)
DSM-5
defined
Use
Disorder
(CUD).
retrospective
chart
review
was
conducted
on
Chinese-speaking
individuals
reporting
from
three
different
substance
studies.
Their
demographic
data,
frequency
within
past
30
days,
scorings
C-SDS-C
severity
CUD
at
baseline
were
analyzed.
The
exhibited
high
reliability
(Cronbach's
alpha
=
0.778).
It
had
a
strong
correlation
(r
0.456,
p
<.001)
moderate
days
0.335,
.001).
All
items
loaded
into
single
factor
which
accounted
56.64%
variance.
Receiver
operating
characteristic
analysis
demonstrated
cut-off
score
≥
3
provided
optimal
discrimination
to
severe
using
cannabis.
valid
reliable
moderate-to-severe
population.
Addiction,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 10, 2025
Abstract
Background
and
Aim
Cannabis
use
disorder
(CUD)
is
strongly
influenced
by
genetic
factors;
however
the
mechanisms
underpinning
this
association
are
not
well
understood.
This
study
investigated
whether
a
polygenic
risk
score
(PRS)
based
on
genome‐wide
for
CUD
in
adults
predicts
cannabis
adolescents
can
be
explained
inter‐individual
variation
structural
properties
of
brain
white
matter
or
risk‐taking
behaviors.
Design
setting
Longitudinal
cross‐sectional
analyses
using
data
from
IMAGEN
cohort,
European
longitudinal
integrating
genetic,
neuroimaging
behavioral
measures.
We
measured
associations
between
PRS
CUD,
novelty
sensation
seeking
traits
fractional
anisotropy
(FA)
tracts.
Mediation
modeling
explored
FA
mediated
use.
Participants
were
assessed
at
14
(
n
=
1762),
19
1175)
23
1139)
years
old.
Measurements
School
Survey
Project
Alcohol
Other
Drugs,
substance
profile
scale,
Fagerstrom
Test
Nicotine
Dependence,
temperament
character
inventory,
Kirby
Monetary
Questionnaire,
diffusor
tensor
imaging
CUD‐PRS.
Findings
CUD‐PRS
was
associated
with
adolescent
total
exposure
[
P
<
0.001,
beta
0.098
(95%
confidence
interval
0.059,
0.137)]
as
other
measures
[alcohol
0.002,
0.058
(0.020,
0.096);
cigarettes
smoked
0.086
(0.044,
0.128);
fargestrom
0.062
(0.028,
drug
0.106
(0.065,
0.147)].
also
impulsivity,
behaviors
[impulsivity
(0.060,
0.142);
0.094
(0.0523,
0.1357);
0.105
(0.064,
0.146);
discounting
task
0.051
(0.013,
0.089)]
average
−0.010
(−0.015,
−0.005)].
mediation
models
showed
that
these
could
mediate
[overall
indirect
effect
0.048
0.068);
impulsivity
0.016,
0.019
(0.004,
0.035);
0.034
(0.017,
0.05)].
Conclusions
The
adult
appears
to
behavior
structure
early
age
14.
observed
consistent
notion
increases
way
leads
more
adolescents.
The Canadian Journal of Psychiatry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 15, 2025
To
establish
whether
the
risk
of
psychotic
disorders
in
cannabis
users
changes
with
time
following
cessation
using
data
from
European
Network
National
Networks
studying
Gene-Environment
Interactions
Schizophrenia
(EU-GEI)
case-control
study.
The
EU-GEI
study
collected
first
episode
psychosis
patients
and
population
controls
across
sites
Europe
Brazil
between
May
2010
April
2015.
Adjusted
logistic
regressions
were
applied
to
examine
odd
case
status
changed:
(1)
(2)
different
use
groups.
Psychosis
declined
(β
=
-0.002;
95%
CI
-0.004
0.000;
P
0.067).
When
accounting
for
duration
use,
this
effect
remained
-0.003;
-0.005
-0.001;
0.013).
However,
models
adjusting
frequency
potency
result
was
not
significant.
Analysis
groups
indicated
that
ex-users
who
stopped
1
4
weeks
previously
had
highest
disorder
compared
never
(OR
6.89;
3.91-12.14;
<
0.001);
those
5
12
2.70;
1.73-4.21;
0.001)
13
36
1.53;
1.00-2.33;
0.050).
Ex-users
37
96
1.01;
0.66-1.57;
0.949),
97
180
0.73;
0.45-1.19;
0.204),
181
or
more
1.18;
0.76-1.83;
0.456)
similar
never-used
cannabis.
Risk
appears
decline
cessation,
receding
have
used
after
abstinence.
Although,
preliminary
results
suggest
frequent
high
types
might
maintain
an
elevated
even
when
abstaining
longer
than
weeks.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 6, 2025
Abstract
Background
The
Hierarchical
Taxonomy
of
Psychopathology
(HiTOP)
and
Research
Domain
Criteria
(RDoC)
frameworks
emphasize
transdiagnostic
mechanistic
aspects
psychopathology,
respectively.
We
used
a
multi-omics
approach
to
examine
how
externalizing
(EXT),
internalizing
(INT),
shared
EXT+INT
liability
map
onto
these
models.
Methods
conducted
analyses
across
five
RDoC
units
analysis:
genes,
molecules,
cells,
circuits,
physiology.
Using
genome-wide
association
studies
from
the
companion
Part
I
article,
we
identified
genes
tissue-specific
expression
patterns.
drug
repurposing
that
integrate
gene
annotations
identify
potential
therapeutic
targets
single-cell
RNA
sequencing
data
implicate
brain
cell
types.
then
magnetic
resonance
imaging
regions
circuits
associated
with
each
psychopathology
spectrum.
Finally,
tested
causal
relationships
between
spectrum
physical
health
conditions.
Results
identification
methods,
EXT
was
1,759
INT
454
1,138
genes.
Drug
targets,
including
those
affect
dopamine
serotonin
pathways.
Expression
enriched
in
GABAergic,
cortical,
hippocampal
neurons,
while
were
more
narrowly
linked
GABAergic
neurons.
reduced
gray
matter
volume
amygdala
subcallosal
cortex.
Mendelian
randomization,
showed
stronger
effects
on
health—including
chronic
pain
cardiovascular
diseases—than
EXT.
Conclusions
Our
findings
revealed
distinct
pathways
underlying
psychopathology.
Integrating
genomic
insights
HiTOP
advanced
our
understanding
mechanisms
underlie